Letters: Bisphenol A 'risk' must be viewed with caution

In response to your recent article reporting a possible link between articles produced using bisphenol A (BPA) and adverse effects on human health (GP, 19 September), the British Plastics Federation urges great caution when assessing the results of the study on which your report is based.

The authors themselves state that their study does not conclusively demonstrate that humans are experiencing adverse health effects as a result of the general population's exposure to BPA.

Furthermore, they conclude that their approach may have resulted in false-positive associations and any link is merely statistical.

Consumer products produced using BPA not only contribute to the convenience of every day life but have been safely used for over 50 years.

Rigorous testing by the European Food Safety Authority and other regulatory bodies worldwide confirm its safety and support its continued use.

Sarah Plant, British Plastics Federation, London.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...